FDA Plans to Expedite Product Reviews by Hiring More Staff

Drug Industry Daily
The FDA hopes to bolster its scientific staff in 2018 — not only to expedite product reviews, but to meet its commitments to industry under the user fee agreements — by implementing a pilot hiring program focused on addressing the approximately 15 percent of positions currently unfilled at CDER and CBER, which total about 1,000 vacancies.

To View This Article:


Subscribe To Drug Industry Daily